| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.036 | 0.5 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | -0.12 | 0.5 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.035 | 0.5 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | -0.03 | 0.5 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |